Jon Congleton
Chief Executive Officer at MINERALYS THERAPEUTICS, INC.
Net worth: 16 M $ as of 2024-04-29
Jon Congleton active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Director/Board Member | - | - |
| Chief Executive Officer | 2020-10-31 | - | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Private Equity Investor | - | - |
Career history of Jon Congleton
Former positions of Jon Congleton
| Companies | Position | Start | End |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director/Board Member | - | 2020-05-04 |
| Chief Executive Officer | 2017-10-02 | 2020-05-04 | |
| President | 2017-10-02 | 2020-05-04 | |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Director/Board Member | 2014-12-21 | 2017-01-14 |
| Chief Executive Officer | 2014-12-21 | 2017-01-14 | |
| President | 2014-12-21 | 2017-01-14 | |
| ALPINE IMMUNE SCIENCES, INC. | Chief Executive Officer | - | 2016-12-31 |
| President | - | 2016-12-31 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Sales & Marketing | - | - |
Teva Neuroscience, Inc.
 Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Corporate Officer/Principal | 2010-11-18 | - |
Training of Jon Congleton
| Kansas State University | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Israel | 2 |
| Japan | 2 |
Operational
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
| President | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Teva Neuroscience, Inc.
Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Finance |
- Stock Market
- Insiders
- Jon Congleton
- Experience